| Bioactivity | HFI-142 is an insulin-regulated aminopeptidase (IRAP) inhibitor with a Ki of 2.01 μM[1]. | |||||||||
| Target | Ki: 2.01 μM (Insulin-regulated aminopeptidase) | |||||||||
| Name | HFI-142 | |||||||||
| CAS | 332164-34-8 | |||||||||
| Formula | C17H16N2O4 | |||||||||
| Molar Mass | 312.32 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Albiston AL, et al. Phenylalanine-544 plays a key role in substrate and inhibitor binding by providing a hydrophobicpacking point at the active site of insulin-regulated aminopeptidase. Mol Pharmacol. 2010 Oct;78(4):600-7. |